首页> 外文OA文献 >Mo1445 – The Performance of Triple Biomarkers (AFP, AFP-3, DCP) for Early Detection of Hepatocellular Carcinoma (HCC). A Prospective Cohort Phase 3 Biomarker Study in the United States

【2h】

Mo1445 – The Performance of Triple Biomarkers (AFP, AFP-3, DCP) for Early Detection of Hepatocellular Carcinoma (HCC). A Prospective Cohort Phase 3 Biomarker Study in the United States

机译：MO1445 - 用于早期检测肝细胞癌（HCC）的三重生物标志物（AFP，AFP-3，DCP）的性能。美国前瞻性队列第3期生物标志物研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hashem B. El-Serag; Nabihah Tayob; Fasiha Kanwal; Abeer Alsarraj; Ruben Hernaez;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase 3 biomarker study for HCC surveillance using AFP, AFP-L3 and DCP: A prospective collection with retrospective blinded evaluation [J] . El-Serag Hashem B., White Donna, Tayob Nabhah, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：第3阶段使用AFP，AFP-L3和DCP研究HCC监测的生物标志物研究：具有回顾性盲目评估的潜在收集
2. Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: A comparison of AFP, DCP, and AFP-L3 [J] . Michael L. Volk, Jose C. Hernandez, Grace L. Su, Cancer Biomarkers . 2007,第2期

机译：肝细胞癌的危险因素可能会损害生物标志物的性能：AFP，DCP和AFP-L3的比较
3. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage [J] . Ping Luo, Sanyun Wu, Yalan Yu, Pathology oncology research: POR . 2020,第2期

机译：AFP阴性HCC中的当前状态和透视生物标志物：在早期阶段筛选和诊断肝细胞癌
4. AN INTEGRATED MICROFLUIDIC DEVICE FOR QUANTITATIVE MEASUREMENT OF HEPATOCELLULAR CARCINOMA (HCC) BIOMARKERS IN WHOLE BLOOD SAMPLES [C] . Chen Li, Say Yang, Ring-Ling Chien International Conference on Miniaturized Systems for Chemistry and Life Sciences . 2011

机译：全血样品中肝细胞癌（HCC）生物标志物定量测量的集成微流体装置
5. Hepatocyte specific GP73/GOLM1 knockout mice and human hepatocellular carcinoma cell lines provide insights into the potential roles of GP73 HCC serum biomarker. [D] . Arora, Gunisha. 2016

机译：肝细胞特异的GP73 / GOLM1基因敲除小鼠和人肝癌细胞系提供了洞察GP73 HCC血清生物标志物潜在作用的信息。
6. Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response [O] . Winnie Yeo, Stephen L Chan, Frankie KF Mo, 2015

机译：替莫西莫司用于无法切除的肝细胞癌（HCC）患者的I / II期研究-相关研究以探讨潜在的反应生物标志物
7. Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response [O] . Winnie Yeo, Stephen L Chan, Frankie KF Mo, 2015

机译：替莫西莫司用于无法切除的肝细胞癌（HCC）患者的I / II期研究-相关研究以探讨潜在的反应生物标志物

Mo1445 – The Performance of Triple Biomarkers (AFP, AFP-3, DCP) for Early Detection of Hepatocellular Carcinoma (HCC). A Prospective Cohort Phase 3 Biomarker Study in the United States

著录项

引文网络

相似文献

相关主题

期刊订阅